Abstract CT123: IMvoke010: Randomized Phase III study of atezolizumab as adjuvant monotherapy after definitive therapy of squamous cell carcinoma of the head and neck (SCCHN)
Year: 2019
Type: conference-abstract
Source: Clinical Trials
Institutions: UCLA Medical Center, Centre Léon Bérard, Shanghai East Hospital, F. Hoffmann-La Roche AG, University of California San Diego, Institut Català d'Oncologia, Prince of Songkla University, Tata Memorial Hospital, Cleveland Clinic, Centre for Cancer Biology, University Medical Center Freiburg, Genentech, University of Colorado Denver, Dana-Farber Cancer Institute
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2953899047